Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 3 Effect of flaxseed oil supplementation on AEA status

From: Effect of flaxseed oil supplementation on the erythrocyte membrane fatty acid composition and endocannabinoid system modulation in patients with coronary artery disease: a double-blind randomized controlled trial

Variable

Flaxseed oil (n = 21)

Placebo (n = 19)

MD (95% CI), P value

AEA (ng/ml)

 Before

5.45 (2.98)

6.76 (2.72)

1.31 (− 0.54 to 3.17), 0.158a

 After

4.73 (2.67)

6.44 (2.44)

0.64 (0.12 to 1.15), 0.016b

MD (95% CI), P valuec

− 0.71 (− 1.08 to − 0.34), 0.001

− 0.32 (− 0.70 to 0.05), 0.091

 
  1. Values are expressed as mean (SD)
  2. AEA N-arachidonoyl ethanolamine, MD mean difference
  3. aIndependent samples t-test
  4. bAdjusted for baseline values, weight differences, energy intake changes and fat intake changes using the analysis of covariance (ANCOVA) test
  5. cPaired-samples t-test
Back to article page

Genes & Nutrition

ISSN: 1865-3499

Contact us